Építés alatt – nem éles oldal
Belépés
Leállítva3. fázis

A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction

A legfontosabb adatok

Ki végzi
Negovsky Reanimatology Research Institute
Hol
Oroszország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Leállítva
Fázis
3. fázis
Résztvevők
107 fő vett részt
Kezdés
2021. nov. 20.
Befejezés
2025. máj. 19.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • Lithium Carbonate
  • Placebo
A regiszteradat frissítve
2025. szeptember 25.
Miért állt le
Decision of the local ethics committee

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt
A regiszter összes feltétele (18)A regiszter feltételeinek elrejtése

Ki vehet részt

  • age > 18 years
  • elective carotid artery surgery
  • general anesthesia
  • written informed consent

Ki nem vehet részt

  • urgent surgery
  • Previously enrolled in this trial
  • recent ( < 1 month) overt stroke
  • The presence of any mental disorder according to the International Classification of Diseases 11th Revision which is confirmed by a psychiatrist
  • The presence of any neuromuscular disease according to the International Classification of Diseases 11th Revision
  • Hypersensitivity or known allergy to lithium carbonate
  • History of seizure disorder
  • History of leukemia
  • Heart failure equal 3 or 4 class according to the New York Heart Association Functional Classification
  • Left ventricular ejection fraction < 30%
  • Mini-mental State Examination < 20 points
  • Estimated glomerular filtration rate < 30 ml/min/1.73 m2
  • Pregnant or breast-feeding women
  • Inability to undergo a preoperative assessment for any reason

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

There are 10.3 million cases of stroke registered in the world every year; 63% of them lead to death. According to World Health Organization, stroke is one of the most important risk factors of death and early disability.

A teljes eredeti leírásKevesebb

Carotid artery surgery is a gold standard of hemodynamically significant carotid artery disease treatment. According to some trials, carotid artery surgery decreases the 2-years mortality.

The most important part of carotid artery surgery is a temporary absence of blood flow in the carotid artery. The duration of this period is a crucial characteristic of this type of surgery. The absence of blood flow leads to brain ischemia which is the risk factor of postoperative neurocognitive disorders such as emergence delirium, postoperative delirium and postoperative cognitive dysfunction.

Some surgical and non-surgical methods for brain protection were evaluated. According to recent data, there is no evidence of effective pharmacological protective methods that can decrease brain damage during carotid artery surgery.

Nevertheless, some trials demonstrated that using lithium-based medications for patients with a stroke can reduce the volume of the stroke. Therefore, the investigators want to check the hypothesis that using lithium-based medication in the preoperative period can reduce brain damage during carotid artery surgery.

The objectives of this trial:

1. To determine if Lithium carbonate is superior to placebo for the occurrence of emergence delirium, agitation, postoperative delirium and postoperative cognitive dysfunction. 2. To determine if Lithium carbonate is non-inferior to placebo for the occurrence of a new arrhythmia, leukocytosis, acute kidney injury, seizure disorders, diarrhea, nausea, and vomit.

A vizsgálat 2 csoportja

  • LithiumA vizsgált kezelés

    In preoperative period patients will take 300mg of lithium carbonate on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take 300mg of lithium carbonate 2 hours before surgery. After the surgery, patients will take 300mg of lithium carbonate in the afternoon and 300mg of lithium carbonate in the evening.

    Kezelés: Lithium Carbonate

  • PlaceboPlacebo, összehasonlításként

    In preoperative period patients will take placebo on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take placebo 2 hours before surgery. After the surgery, patients will take placebo in the afternoon and in the evening.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction: A Double-Blind, Placebo Control Randomized Trial (BINOS)
A regiszteradat frissítve
2025. szeptember 25.